|
1
|
Meguid RA, Hooker CM, Taylor JT, Kleinberg
LR, Cattaneo SM II, Sussman MS, Yang SC, Heitmiller RF, Forastiere
AA and Brock MV: Recurrence after neoadjuvant chemoradiation and
surgery for esophageal cancer: Does the pattern of recurrence
differ for patients with complete response and those with partial
or no response? J Thorac Cardiovasc Surg. 138:1309–1317. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Quint LE, Hepburn LM, Francis IR, Whyte RI
and Orringer MB: Incidence and distribution of distant metastases
from newly diagnosed esophageal carcinoma. Cancer. 76:1120–1125.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Mariette C, Balon JM, Piessen G, Fabre S,
Van Seuningen I and Triboulet JP: Pattern of recurrence following
complete resection of esophageal carcinoma and factors predictive
of recurrent disease. Cancer. 97:1616–1623. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hulscher JB, van Sandick JW, Tijssen JG,
Obertop H and van Lanschot JJ: The recurrence pattern of esophageal
carcinoma after transhiatal resection. J Am Coll Surg. 191:143–148.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Abbas S, Lam V and Hollands M: Ten-year
survival after liver resection for colorectal metastases:
Systematic review and meta-analysis. ISRN Oncol.
2011:7632452011.PubMed/NCBI
|
|
6
|
Huddy JR, Thomas RL, Worthington TR and
Karanjia ND: Liver metastases from esophageal carcinoma: Is there a
role for surgical resection? Dis Esophagus. 28:483–487. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Scorsetti M, Arcangeli S, Tozzi A, Comito
T, Alongi F, Navarria P, Mancosu P, Reggiori G, Fogliata A,
Torzilli G, et al: Is stereotactic body radiation therapy an
attractive option for unresectable liver metastases? A preliminary
report from a phase 2 trial. Int J Radiat Oncol Biol Phys.
86:336–342. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Niibe Y and Hayakawa K: Oligometastases
and oligo-recurrence: The new era of cancer therapy. Jpn J Clin
Oncol. 40:107–111. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Niibe Y and Chang JY: Novel insights of
oligometastases and oligo-recurrence and review of the literature.
Pulm Med. 2012:2610962012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hellman S and Weichselbaum RR:
Oligometastases. J Clin Oncol. 13:8–10. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Iitaka D, Shiozaki A, Fujiwara H, Ichikawa
D, Okamoto K, Komatsu S, Murayama Y, Ikoma H, Kuriu Y, Nakanishi M,
et al: Case involving long-term survival after esophageal cancer
with liver and lung metastases treated by multidisciplinary
therapy: Report of a case. Surg Today. 43:556–561. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Almaghrabi MY, Supiot S, Paris F, Mahé MA
and Rio E: Stereotactic body radiation therapy for abdominal
oligometastases: A biological and clinical review. Radiat Oncol.
7:1262012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
de Vin T, Engels B, Gevaert T, Storme G
and De Ridder M: Stereotactic radiotherapy for oligometastatic
cancer: A prognostic model for survival. Ann Oncol. 25:467–471.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yamashita H, Onishi H, Matsumoto Y,
Murakami N, Matsuo Y, Nomiya T and Nakagawa K: Japanese
Radiological Society multi-institutional SBRT study group
(JRS-SBRTSG): Local effect of stereotactic body radiotherapy for
primary and metastatic liver tumors in 130 Japanese patients.
Radiat Oncol. 9:1122014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Milano MT, Katz AW and Okunieff P:
Patterns of recurrence after curative-intent radiation for
oligometastases confined to one organ. Am J Clin Oncol. 33:157–163.
2010.PubMed/NCBI
|
|
16
|
Egawa T, Okubo Y, Kemmochi T, Mori T, Sato
S, Nishiya S, Mihara K, Ito Y, Makino H and Nagashima A: A case of
liver metastasis from esophageal cancer treated with stereotactic
body radiation therapy. Gan To Kagaku Ryoho. 40:1850–1852. 2013.(In
Japanese). PubMed/NCBI
|
